Given the evidenced benefits of BPC-157 on neurological health, including neuroprotection, neurotransmitter modulation, and the maintenance of systemic homeostasis via the brain-gut axis, it may be particularly suited to nasal administration
weight gain DPP-4 inhibitors (sitagliptin, linagliptin): Incretin-based
Important: Only injectable semaglutide (Wegovy), injectable tirzepatide (Zepbound), and oral semaglutide 25 mg (oral Wegovy) are FDA-approved for weight management
Designed for IV use by licensed professionals in clinical or wellness settings
A GLP-1 like Ozempic is judged by whether your gut has recovered, while an SGLT2 inhibitor like Jardiance is resumed once you are clinically stable and eating normally to avoid ketoacidosis
A: We know pretty directly the actions that we took to drive these results